Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA in Cholestatic Drug-induced Liver Injury
NCT01141322Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Aug 2007
- Primary completion
- Apr 2010
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ursodeoxycholic acid in drug induced liver injury (DILI), sponsored by Taipei Veterans General Hospital. Primary endpoint: Severe degree drug-induced liver injury, fatality or liver transplantation at 8 weeks. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT01141322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141322.